Related Experiment Video

Updated: Nov 17, 2025

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
10:50

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging

Published on: June 29, 2013

12.6K

Medical therapy for cardiovascular and limb-related risk reduction in critical limb ischemia

Stefanos Giannopoulos1, Ehrin J Armstrong1

  • 1Division of Cardiology, Rocky Mountain Regional VA Medical Center, University of Colorado, Denver, CO, USA.

Vascular Medicine (London, England)
|February 15, 2021
PubMed

Insights

Optimized medical care, including cardioprotective medications and risk factor modification, can significantly reduce cardiovascular and limb events in critical limb ischemia (CLI) patients, improving quality of life and survival rates.

Area of Science:

  • Vascular Medicine
  • Cardiology
  • Peripheral Artery Disease Management

Background:

  • Critical limb ischemia (CLI) is the most severe stage of peripheral artery disease (PAD).
  • CLI presents with ischemic rest pain, tissue loss, or gangrene, significantly impacting patient quality of life and survival.
  • Effective management requires a multi-faceted approach beyond revascularization.

Purpose of the Study:

  • To review guideline-recommended therapies for critical limb ischemia (CLI).
  • To examine the role of optimized medical care and risk factor modification in reducing cardiovascular and limb-related events in CLI patients.
  • To highlight the importance of adherence to cardioprotective medications.

Main Methods:

  • Systematic review of current clinical guidelines and relevant literature.
  • Analysis of evidence supporting cardioprotective medications and risk factor modification strategies.
  • Evaluation of therapeutic benefits on cardiovascular and limb outcomes in CLI.

Main Results:

  • Optimized medical care, including antithrombotic therapy, cholesterol-lowering agents (statins, PCSK9 inhibitors), ACE inhibitors/ARBs, and smoking cessation, is crucial.
  • Adherence to these therapies can decrease cardiovascular events and major adverse limb events.
  • Improved patient quality of life and survival rates are associated with comprehensive management.

Conclusions:

  • Guideline-recommended medical therapies are essential for managing critical limb ischemia (CLI).
  • Aggressive risk factor modification and consistent medication adherence improve both limb and cardiovascular outcomes.
  • A holistic approach integrating medical management with revascularization offers the best prognosis for CLI patients.

Keywords:
anti-hypertensive therapyanti-platelet therapycardioprotective medicationcritical limb ischemia (CLI)medical therapysmoking cessationstatins

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.6K
Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia07:48

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia

Published on: June 8, 2019

9.0K

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
112
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
113
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
124
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
123
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
112
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
153